… pharmacological products to treat osteoporotic patients. … products play a key role in the
treatment of osteoporosis and … primary pharmacological products used to treat osteoporosis. …

… Pharmacological therapy is the mainstay of interventions for patients with osteoporotic
fractures. Indeed, commercially available anti-osteoporotic drugs are supported by substantial …

… Osteoporosis is a common disease characterized by low … that pharmacological therapy can
reduce the risk of fractures. In clinical practice, however, failure to achieve optimal therapeutic …

… Pharmacological therapies that effectively reduce the number of fractures by improving
bone mass are now available widely in countries around the world. Most current agents inhibit …

… therapy as part of routine medical care are not available. Such data could help determine
the effectiveness of osteoporosis therapy in a "… a first prescription for osteoporosis treatment. …

… Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal …
Pharmacological management of osteoporosis in postmenopausal women: an Endocrine …

… The goal of treating patients with or at risk for osteoporosis is … This article focuses on
pharmacologic therapy aimed at … drug therapies for the treatment and prevention of osteoporosis (…

… Patients discontinuing therapy should be reevaluated periodically in order to decide if
pharmacologic therapy should be restarted. Timing of reevaluation has been suggested 1 year …

… Osteoporosis was a huge global problem both socially and economically – in the UK alone,
… 230,000 osteoporotic fracture patients – and therefore viable preventative and therapeutic …

… Although substantial progress has been made in the last decade in the pharmacologic
prevention of osteoporotic fractures, the presently available therapies are limited in number and …